The objective of the registry is to collect procedural outcomes data when the Cardiva VASCADE Vascular Closure System (VCS) is used to seal femoral arterial access sites at the completion of ipsilateral peripheral interventional procedures performed through 5-7F introducer sheaths via an antegrade approach.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time to Hemostasis (TTH)
Timeframe: Procedural, usually within 15 minutes of enrollment
Major Access Site Closure-related Complications
Timeframe: Through 30 days +/- 7 days